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Abstract 
The single crystal diffraction structures of seven coordination polymers formed by Ag(I) and bipyridyl 
azine ligands are described and compared. All contain organic anions derived from intrinsically 
functional molecules, either Active Pharmaceutical Ingredients (API = salicylate or diclofenac) or 
carboxylate or sulfonate monoazo dyes. Five of the seven coordination polymers, including all those that 
feature API species,  are found to display variations on a common structural motif, with polymeric 
[Ag(azine)]n chains linked into pairs through argentophillic Ag-Ag contacts supported by a pair of 
AgOXOAg (X = C or S) bridges. Also reported are the crystal structures of two Ag(I) complexes of 
sulfonated monoazo dyes, including the first such structure to feature a Ag to azo dative bond. 
  
 Introduction 
Coordination polymers and metal organic frameworks (MOFs) can be formed from a wide variety of 
metal ions and bipyridyl-based ligands. These species normally also contain an anionic counterion. 
Discussions on chemical functionality typically concentrate on the nature of the metal ion and of the 
bipyridyl ligand, with the counterion relegated to being a chemically inactive bystander which is of 
interest only in as much as it influences the final three dimensional structure of the solid. The structural 
roles of typical small counterions (e.g. NO3
-, BF4
-, PF6
-, SO4
2-) have been much discussed for Ag(I) bipyridyl 
coordination polymers.[1,2] These polymers have outwardly simple structures where two coordinate 
Ag(I) centres and approximately linear ligands give one dimensional polymeric molecules. However, 
when investigated the structural roles of even these simple counterions are non-trivial. They can form a 
wide variety of short range Ag...anion contacts and thus, together with other non-covalent 
intermolecular interactions, they strongly influence how the polymeric Ag-bipyridyl chains interact and 
pack. [1,2] 
Similar Ag(I) structures with larger, organic anions are less common and are mostly limited to aromatic 
anions bearing multiple carboxylate or sulfonate groups. [3-7] These functionalised anions are of course 
designed to interact with Ag(I) and thus they are usually introduced for structural reasons rather than 
due to any great interest in the chemical properties of the ions themselves. There are relatively few 
examples of coordination polymers or MOFs where the counterion is a large organic species that is 
chemically active in its own right. [7] Herein we present the structures of seven Ag(I) coordination 
polymers with chemically active counterions. Ag(I) was chosen as it is relatively well tolerated by the 
body and is used pharmaceutically for its antibacterial functionalities. [8,5] The bipyridyl ligands are 
chosen partly as earlier work on these ligands allows comparisons to be made with equivalent simple 
anion containing species and partly with the long term aim of utilising their central chromophores as 
signalling devices. The counterions used are derived either from well known Active Pharmaceutical 
Ingredients (APIs) that contain carboxylic acid groups (salicylic acid, diclofenac) or from azo dyes that 
contain carboxylic or sulfonic acid groups, see scheme 1. The chemicophysical properties of such API and 
dye molecules are routinely tailored either by salt formation or (for the APIs) by cocrystal formation. [9, 
10] The structures of the chosen counterion formers ? salt forms and cocrystal forms have thus been 
widely studied. [11-24] We present these new structures both to investigate the structural effect of 
introducing large anions into Ag(I) bipyridyl structures and because including such counterions within 
coordination polymers opens up the possibility of dramatic changes to the chemicophysical properties 
of the counterion (e.g. aqueous solubility, dissolution rate and mechanical strength) and thus is a 
potential route to new and improved formulations. [5, 8] 
 
Scheme 1. Ligands used showing their given names. Monoazo dye species are shown in their anionic 
forms. 
Results and Discussion 
All complexes were prepared by first isolating the Ag(I)  complex of the desired API or dye. This was 
accomplished by simple reaction of AgNO3 with Na salts of the relevant organic acid (HY). Suitable 
crystals of the bipyridyl (L) coordination complexes were then prepared by layering solutions of AgY with 
solutions of the bipyridyl ligands thus allowing slow mixing of the reagents.  
Ag API coordination polymers: Four acceptable quality crystal structures containing [AgL][Y] complexes 
were obtained for API relevant carboxylate counterions, see Table 1. Both [AgL1][sal] (sal = salicylate) 
and [AgL2][sal] have structures that share many of the structural  features typical of the related 
compounds with small anions that have already been reported in the literature [1,2]. Dative Ag-
N(pyridyl) bonding thus creates 1-dimensional [AgL]n chains formed by the 2-coordinate Ag(I) centres 
and the approximately linear ligands. [AgL2][sal] contains an azine ligand with the meta pyridyl 
geometry and this forms a more pronounced zig-zag polymer than is seen for the L1 complex, compare 
Figures 1 and 2.  This is also shown by the Ag-E ?EĂŶŐůĞƐ ?ǁŚĞƌĞE ?EƌĞƉƌĞƐĞŶƚƐƚŚĞƚǁŽƉǇƌŝĚǇůE
atoms of a single ligand). For [AgL1][sal] there are two crystallographically independent Ag centres and 
these angles are 165.7 and 168.6°, whilst the equivalent angle for [AgL2][sal] is 122.6°. 
 
Figure 1. Part of the polymeric structure of [AgL1][sal] showing two [AgL1]n chains linked by Ag-Ag 
interactions and by bridging carboxylate groups. Here and in the following figures; Ag = purple, O = red, 
N= blue, C = grey. 
 
 
Figure 2. Part of the polymeric structure of [AgL2][sal]. As with [AgL1][sal], shown in Figure 1, there are 
two [AgL]n chains linked by Ag-Ag interactions and by bridging carboxylate groups.  Note that the [AgL2]n 
chains are not as linear as the equivalent chains in [AgL1][sal]. 
Table 1: Selected crystallographic parameters for API containing silver(I) coordination polymers. 
Compound [AgL1][sal] [AgL2][sal] [AgL2] 
[diclofenac] 
[AgL3] 
[diclofenac]. 
Hdiclofenac 
Formula C19 H15 Ag N4 O3 C19 H15 Ag N4 O3 C26.64 H21.14 Ag Cl2.72 N5.14 O2 C42 H35 Ag Cl4 N6 O4 
Included solvent 
  MeCN/DCM 
(28:72) 
 
Formula weight 455.22 455.22 649.66 937.43 
Crystal system triclinic monoclinic triclinic triclinic 
Space Group P-1 P21/n P-1 P-1 
ʄ 0.71073 0.71073 0.71073 0.71073 
a  Å 10.0038(5) 8.1200(6) 6.8116(1) 13.3362(6) 
b  Å 13.3770(7) 9.7869(6) 13.5608(2) 16.5265(8) 
c  Å 14.291898) 21.6736(16) 28.7557(6) 20.1331(7) 
ɲȗ 71.640(3) 90 95.438(2) 66.518(4) 
E  ȗ 78.179(3) 97.433(7) 95.833(2) 75.035(3) 
ɶȗ 78.327(3) 90 96.716(2) 89.409(4) 
Volume Å3 1757.03(16) 1707.9(2) 2608.96(8) 3910.3(3) 
Temp. K 123(2) 123(2) 100(2) 100(2) 
Z 
4 4 4 4 
͛ 2 1 2 2 
Refls. Collected 26245 16401 31146 47857 
Refls. Unique 26245
a 4437 11757 16978 
Rint n.a.
a 0.0340 0.0199 0.0468 
Goodness of Fit 0.982 1.051 1.049 1.016 
R[I>2V(I)], F 0.0635 0.0285 0.0247 0.0451 
Rw, F2 0.1439 0.0693 0.0567 0.1053 
a This structure was found to be twinned and was refined against a hklf5 formatted reflection file. See 
ESI for further information. 
  
Table 2. Geometric parameters that describe the Ag(I) environment of the polymeric species. 
 [AgL1][
sal] 
[AgL1][s
al] ? 
[AgL2][s
al] 
[AgL2] 
[diclofen
ac] 
[AgL2] 
[diclofen
ac] ? 
[AgL3] 
[diclofenac].Hdicl
ofenac 
[AgL3] 
[diclofenac].Hdicl
ofenac ? 
[AgL2
] 
[DyeA
] 
[AgL3] 
[DyeB] 
AgL3] 
[DyeC] 
Dative 
bonds 
          
Ag-
N(Py) 
2.170(5
) 
2.154(6) 2.19419
17) 
2.1881(1
5) 
2.1918(1
6) 
2.176(2) 2.172(2) 2.205
(6) 
2.158(3
) 
2.161(
2) 
Ag-
N(Py) 
2.175(6
) 
2.154(6) 2.1976(
17) 
2.1970(1
4) 
2.1964(1
5) 
2.178(2) 2.173(2) 2.264
(6) 
2.162(3
) 
2.167(
2) 
Py-Ag-
Py 
173.3(2
) 
175.3(3) 169.30(
6) 
161.53(6
) 
163.36(6
) 
168.53(9) 166.57(9) 144.2
(2) 
171.63(
10) 
172.68
(9) 
Ag---
anion 
          
Ag---O 2.594(6
) 
2.671(6) 2.6630(
16) 
2.5109(1
4) 
2.4887(1
4) 
2.682(2) 2.689(2) 2.357
(5) 
2.643(2
) 
2.630(
2) 
Ag---O 2.821(6
) 
3.069(6) 2.7072(
15) 
2.985(4) 2.927(4) 2.734(2) 2.845(2) 2.842
(6) 
2.881(2
) 
2.924(
3) 
Ag---O 3.237(6
) 
3.164(6)      3.214
(7) 
  
Ag---ʋ           
Ag---C 
or N 
(shorte
st) 
  3.2526(
19) 
(azine 
N) 
3.590(1) 
(py C) 
3.466(1) 
(py C) 
   3.423(3
) 
(py C) 
3.480(
3) 
(pheno
l C) 
Ag---
Ag 
          
Ag---
Ag 
3.4944(
12) 
3.4238(
12) 
2.9962(
4) 
3.0597(3
) 
3.0164(3
) 
3.1650(5) 3.1051(5)  3.2235(
6) 
 
 
  
  
Figure 3. The structure of [AgL2][diclofenac] differs from the salicylate species shown in figures 1 and 2 
in having a highly asymmetric interaction between the Ag-Ag unit and the carboxylate group. 
In both compounds each Ag centre makes 4 short contacts, in addition to the two dative Ag-N bonds, 
giving a pseudo-octahedral geometry. The individual dative chains are linked into pairs by argentophilic 
Ag-Ag short contacts [1,2,25] which are each supported by two COO bridges from the benzoate anions,  
giving pairs of [AgAgOCO] five-membered rings. A difference between the two structures lies in the 
geometric detail of these rings. The Ag-Ag contact in [AgL1][sal] is much longer than that in [AgL2][sal] 
and indeed is longer than any of the other Ag-Ag contacts reported in Table 2. Additionally,  the two Ag-
O distances per ring are asymmetric for [AgL1][sal] but near equivalent In [AgL2][sal], see distances 
given in Table 2. Both compounds described so far thus give rather similar double-chain, 1-dimensional 
polymers. However, the 6th contact site of each Ag centre is that trans to the Ag-Ag bond and differs 
between the compounds and thus so does the method of double-chain to double-chain interaction, 
Table 3. In the structure of [AgL1][sal] both independent Ag centres make a short contact with an O 
atom of the salicylate anion of a neighbouring double chain, but one Ag centre contacts an O atom of a 
COO group whilst the other interacts with the O atom of the phenolic group. These contacts link double 
chains in the crystallographic b direction. In contrast, tŚĞƐŝǆƚŚƐŝƚĞŝŶ ?Ő> ? ? ?ƐĂů ?ŝƐĂʋĐŽŶƚĂĐƚďĞƚǁĞĞŶ
Ag and a N atom ŽĨƚŚĞĐĞŶƚƌĂůĂǌŝŶĞůŝŶŬĞƌĨƌĂŐŵĞŶƚ ?dŚŝƐŝŶƚĞƌĂĐƚŝŽŶŝƐƐƵƉƉŽƌƚĞĚďǇƐŚŽƌƚʋ-ʋ contacts 
between the azine ligands (closest C to C contact 3.3248(2) Å ) ?dŚĞƐĞʋŝŶƚĞƌĂĐƚŝŽŶƐĐŽŵďŝŶĞƚŽůŝŶŬƚŚĞ
double chains of [AgL2][sal]. In both cases the resulting packed structure is layered with alternating 
organic (hydrophobic) and inorganic (hydrophilic) layers. A related Ag(I) structure with the carboxylate-
based ibuprofen anion and a bipyridyl ligand with a C3H6  linker between its pyridyl rings has been 
published. [7] Despite a very different pyridyl ligand geometry caused by the flexibility of the C3H6 alkyl 
linkage, this has a somewhat similar structure featuring chains of [AgL]n bridged by Ag-Ag contacts. 
However, in this literature compound the COO group does not bridge between the Ag-Ag centres and 
the Ag-Ag bonds link the chains not into pairs but into 2-dimensional sheets.    
Table 3. Summary of pertinent structural features of the polymeric species. 
Compound [AgL1][sal] [AgL2][sal] [AgL2] 
[diclofenac] 
[AgL3] 
[diclofenac]. 
Hdiclofenac 
[AgL2] 
[DyeA] 
[AgL3] 
[DyeB] 
[AgL3] 
[DyeC] 
Double chain 
structure 
yes yes yes yes no yes no 
Ag-Ag 
bonding 
yes yes yes yes no yes no 
OCO or OSO 
bridging  
Ag-Ag 
yes yes yes yes no yes no 
Coordination 
number of Ag 
6 6 6 5 5 6 5/6 
Interaction 
type at 6th 
coordination 
site 
Ag...O Ő ? ? ?ʋ ?ĂǌŝŶĞ ) Ő ? ? ?ʋ ?ƉǇ ) ) none none Ő ? ? ?ʋ ?ƉǇ ) ) Disordered 
solvent. 
Ő ?ů
3.419(4) 
Two silver structures containing the diclofenac anion were also obtained. Despite the larger anion size, 
[AgL2][diclofenac] is very similar to the two salicylate structures described above. Both of its 
crystallographically independent AgL2 units propagate into 1-dimensional chains through Ag-N bonds 
and double chains are formed by Ag-Ag interactions that are bridged by the anions ? COO groups. The 
bridging Ag-O contacts are even more asymmetrical than in the structure of [AgL1 sal] (Table 2). As with 
 ?Ő> ? ? ?ƐĂů ? ?ƚŚĞƐŝǆƚŚƐŚŽƌƚĐŽŶƚĂĐƚŝƐĂʋĐŽŶƚĂĐƚƚŽƚŚĞĂǌŝŶ ůŝŐĂŶĚ ?ďƵƚŚĞƌĞƚŚĞďŽŶĚŝƐƚŽƚŚĞƉǇƌŝĚǇů
ring ratheƌƚŚĂŶƚŽƚŚĞĐĞŶƚƌĂůĂǌŝŶĞĨƌĂŐŵĞŶƚ ?ĨƵƌƚŚĞƌĚŝĨĨĞƌĞŶĐĞŝƐƚŚĂƚʋ-ʋĐŽŶƚĂĐƚƐďĞƚǁĞĞŶƚŚĞ
azine ligands are only found between the ligands of a double chain and do not link neighbouring double 
chains to one another. The second Ag/diclofenac structure is chemically rather different. It contains 
both diclofenac anions and neutral, free-acid, molecules of diclofenac and has formula 
[AgL3][diclofenac].Hdiclofenac. dŚŝƐŝƐĂŶŽƚŚĞƌ ? = 2 structure although, unlike [AgL1][sal] and 
[AgL2][diclofenac], both of the independent Ag centres are part of the same polymeric coordination 
chain rather than forming crystallographically independent coordination chains. Despite the inclusion of 
free acid molecules, the same core 1-dimensional polymeric motif of a double chain of [AgL]n units 
supported by an Ag-Ag interaction and its COO bridges is retained. Once again the Ag...O contacts are 
asymmetric  but here there are no shoƌƚĂǌŝŶĞƚŽĂǌŝŶĞʋ-ʋĐŽŶƚĂĐƚƐĂŶĚƚŚĞŐcentre is best described 
as 5-coordinate rather than as 6-coordinate. The preeminent intermolecular contact formed by the free 
acid groups are donation of O-H...O hydrogen bonds from the carboxylic acid groups to the anionic 
diclofenac COO groups that bond to Ag. Both Ag(I) diclofenac structures pack so as to give layered 
structures with alternating AgL and diclofenc layers. The diclofenac layer of [AgL2][diclofenac] also 
contains disordered solvent molecules. 
 
Figure 4. Part of the polymeric structure of [AgL3][diclofenac].Hdiclofenac showing the free acid 
hydrogen bonded to and pendant upon the coordination polymer. 
 
 Figure 5. Part of the polymeric structure of [AgDyeB] showing the tetrahedral coordination geometry at 
Ag(I) centres and the central [AgOSO]2 ring motif. 
 
 
Figure 6. Part of the structure of [AgxNa(1-x)(DyeC)(OH2)2] showing the azo anions acting as links between 
hydrophilic zones that contain metal ions and water.  
  
Table 4: Selected crystallographic parameters for azo dye containing complexes. 
Compound [Ag(DyeB)] [Na(DyeC)] [AgNa(DyeC)] [AgL2] 
[DyeA] 
Basf 
0.4593(16) 
[AgL3] 
[DyeB] 
[AgL3] 
[DyeC] 
Formula 
C12 H9 Ag 
N2 O4 S 
C12 H13 N2 Na 
O6 S 
C12 H13 Ag0.87 
N2 Na0.13 O6 S 
C25 H19 Ag 
N6 O3 
C28 H26 Ag 
N7 O4 S 
C27.5 H25.5 
Ag Cl N6.5 
O4 S 
Included 
solvent 
 2H2O 2H2O  MeCN MeCN/DCM 
(50:50) 
Formula 
weight 
385.14 336.29 410.03 559.33 664.49 686.02 
Crystal 
system 
monoclinic orthorhombic orthorhombic triclinic triclinic triclinic 
Space 
Group 
P21/n Pbca Pbca P-1 P-1 P-1 
ʄ 0.71073 0.71073 0.71073 1.5418 0.71073 0.71073 
a  Å 8.3838(2) 7.1227(3) 7.0886(3) 7.1538(5) 7.1356(5) 11.1773(4) 
b  Å 9.7225(3) 11.9399(2) 11.8816(6) 12.9587(15) 14.0212(11) 11.6004(4) 
c  Å 14.9340(4) 32.5608(9) 32.9373(17) 13.2859(14) 15.4526(9) 12.1880(4) 
ɲȗ 90 90 90 67.835(10) 109.697(4) 81.629(2) 
E  ȗ 94.352(2) 90 90 82.451(7) 101.688(3) 73.899(2) 
ɶȗ 90 90 90 76.606(8) 98.473(30 70.341(2) 
Volume Å3 1213.78(6) 2769.11(15) 2774.1(2) 1108.29(19) 1385.85(17) 1427.43(9) 
Temp. K 123(2) 150(2) 123(2) 123(2) 100(2) 120(2) 
Z 
4 8 8 2 2 2 
͛ 1 1 1 1 1 1 
Refls. 
Collected 
25790 5649 19356 10036 25884 31937 
Refls. 
Unique 
3549 3048 3015 10036a 6336 6545 
Rint 0.0409 0.0826 0.0630 na
a 0.0681 0.0595 
Goodness 
of Fit 
1.067 0.991 1.020 1.066 1.052 1.035 
R[I>2V(I)], 
F 
0.0229 0.0473 0.0319 0.1044 0.0567 0.0392 
Rw, F2 0.0485 0.1052 0.0599 0.2934 0.0932 0.0917 
a This structure was found to be twinned and was refined against a hklf5 formatted reflection file. See 
ESI for further information. 
Ag salts of Dye B and Dye C: Two structures were elucidĂƚĞĚĨŽƌƚŚĞ “ƐƚĂƌƚŝŶŐŵĂƚĞƌŝĂůƐ ?which were 
expected to be Ag(I) salts of DyeB and  DyeC, Table 4. Few structures of Ag salts of sulfonated azo dyes 
are known from the literature, but in those structures that are known [3, 21, 26] the Ag(I) centre 
performs the same structural role as is performed by the heavier alkali metal ions (Na, K, Rb) in 
equivalent compounds. [18-21] For the meta-sulfonated DyeC , the compound isolated was 
predominately a silver salt where as expected Ag  performs the same structural role as a heavy alkali 
metal. Indeed the structure obtained was found to be isomorphous and isostructural with the Na salt 
form of DyeC (given in the ESI for comparison) and even features metal sites with mutual substitution 
disorder with a mix of Ag(I) and Na(I) sharing the same metal site such that the refined formula is 
[AgxNa(1-x)(DyeC)(OH2)2]  (x = 0.867(2)).  However, the structure of [Ag(DyeB)] is different from what has 
been observed previously, with the main and obvious difference being that a Ag-N dative bond (Ag-N 
2.2437(15) Å) has formed between Ag(I) and a N atom of the azo group. No such M-N bond has been 
found for any previously reported alkali metal sulfonated azo dye structure. [18] The closest analogue 
found was a Ag(I) complex of azobenzene  - an azo ligand which offers no Lewis base atoms as potential 
bonding sites apart from its azo group. [31] The Ag-N bond formation does not alter the azo bond length 
(compare 1.264(2) and 1.266(3) Å in [Ag(DyeB)] and [AgxNa(1-x)(DyeC)(OH2)2]). Gas phase calculations 
suggest that sulphonated azo ions prefer planar (and presumably conjugated) conformations.[18] 
However, the aromatic rings in the azo anion of [Ag(DyeB)] are considerably twisted out of plane, the 
angle between ring planes is 49.75(6) °. The solid state structures of such anions do sometimes feature 
non-planar conformations but these are rarely as pronounced as is the case here. Thus it may be that 
the twist is directly related to the Ag-N bond formation. [18] 
Ag dye coordination polymers: The first of the three Ag(I) bipyridyl and azo dye-containing structures, 
[AgL2][Dye A],  is chemically similar to the Ag(I) API containing complexes, above, in as far as the organic 
anion is a carboxylate. Further, it is a derivative of salicylic acid and retains the salicylate metal ion 
bonding  groups. Largely due to twinning of the crystals, the quality of this structure is rather low. 
However, the data clearly demonstrates that this structure is different from the API-containing 
structures. There are no Ag-Ag interactions here. Each Ag centre makes 2 dative bonds to pyridyl N 
atoms as usual, but the N-Ag-N angle is bent away from 180 to 144.2(2)°  by the presence of a Ag-OCO 
bond that is much shorter than the others described herein (2.357(5)Å, see Table 2) . These three dative 
bonds result in the 1-dimensional  coordination polymer illustrated in Figure 7 (top). Note that the 
bipyridyl ligands have crystallographically imposed centres of symmetry  at the middle of the N-N bonds, 
giving two crystallographically independent ligands. Two longer Ag...O contacts are also present and 
have unusual Ag-ʋƚǇƉĞŐĞŽŵĞƚƌŝĞƐ ?dŚĞƐĞĐŽŶƚĂĐƚƐĂƌĞ to neighbouring COO groups and they complete 
the Ag bonding which is thus approximately trigonal bipyrimidal. The long Ag-O interactions link 
individual [AgL2]n chains in the crystallographic a direction. [AgOAgO] and [Ag(OCO)Ag(OCO)] rings are 
formed and these result in the structure being a 2-dimensional polymer.  
 
 
Figure 7. Top, part of the 1-dimensional coordination polymer formed by dative bonding in [AgL2][Dye 
A]. The azo dye anions are pendant to the polymeric chain. Bottom, longer Ag-OCO  contacts hĂǀĞʋ
geometries and link the 1-dimensional coordination polymers in a second dimension. One such series of 
Ag-O interactions has been picked out with thick bonds. 
Of the two Ag(I) complexes that contain sulfonated monoazo dyes as anions, one has a structure that is 
a close relative of the Ag(I) API complexes. The simple difference is that in the structure of 
[AgL3][DyeB].NCMe  asymmetrically bridging SO3 units replace the bridging COO groups seen for the API 
complexes and these perform an equivalent structural role by bridging Ag-Ag argentophilic bonds. The 
sixtŚƐŝƚĞŝŶǀŽůǀĞƐĂŐ ? ? ?ʋŝnteraction with a pyridyl ring and these interactions form links connecting 
neighbouring ĚŽƵďůĞĐŚĂŝŶƵŶŝƚƐ ?^ŚŽƌƚʋ-ʋŝŶƚĞƌĂĐƚŝŽŶƐďĞƚǁĞĞŶĂǌŝŶĞůŝŐĂŶĚƐĞǆŝƐƚǁŝƚŚŝŶƚŚĞĚŽƵďůĞ
chains but also occur between the azo anions of neighbouring molecules  ? and this latter interaction 
also connects neighbouring double chains to each other.  The final Ag(I) structure is a solvate of 
[AgL3][DyeC], where Dye C is the para isomer of meta-sulfonated azo dye,  DyeB. Despite this relatively 
small difference, the structure is very different, with no Ag-Ag bond (Ag to Ag distances > 4.39 Å). The 
usual two trans Ag-N bonds to pyridyl are present giving a 1-dimensional coordination polymer, but the 
remainder ŽĨƚŚĞŐĐĞŶƚƌĞ ?ƐƐŚŽƌƚ contacts are made up of two contacts to O atoms of sulfonate groups 
ĂŶĚŽŶĞʋ-interaction with the phenol ring of an azo anion. The three dimensional packed structure 
results from these Ag to sulfonate ion interactions combining to link single chains of [AgL3]n. The 
potential sixth contact site for Ag is unusual. This space is filled by a mixture of disordered solvent (a 
50:50 mix of MeCN and DCM) and the only contact that is less than the sum of van der Waals radii is a 
Ő ?ůŝŶƚĞƌĂĐƚŝŽŶ ?3.419(4) Å. This highlights a difference between the currently reported structures and 
similar species with small anions.[2] When prepared using the same methods and solvents, almost half 
of the small counterion containing structures had MeCN present as a ligand bound to Ag. Three of the 
seven relevant structures reported herein have MeCN in the crystal structure  ? but none features a Ag-
NCMe bond.  A further oddity of this structure is that although the aromatic rings of the azo anion are 
mutually coplanar, the azine ligand adopts a very twisted conformation (angle between least squares 
planes 65.79(9) °). Such a twisted conformation of the azine ligand has been seen before, for example in 
the complex [AgL1][NO3], but is uncommon. [2] 
 Figure 8. Part of the 1-dimensional double chain structure of [AgL3][DyeB].NCMe , showing structural 
similarity to the salicylate and diclofenac structures reported above. 
 
Figure 9. Part of the 1-dimensional polymeric chain structure of [AgL3][DyeC].solvate illustrating the 
twisted nature of the azine ligand and pendant monoazo anions. These chains are interconnected by Ag-
O3S contacts and by Ag-ʋĐŽŶƚĂĐƚƐ ? 
Conclusions 
This work shows the successful inclusion of functional carboxylate and sulfonate anions into Ag(I) 
bipyridyl coordination polymers. Four structures are reported that contain anionic forms of the Active 
Pharmaceutical Ingredients (APIs) salicylate and diclofenac, and three structures contain anionic 
monoazo dyes. In addition the structure of a silver salt of a meta-sulfonated azo dye, [Ag(DyeB)], is 
reported and is found to contain an unexpected Ag-N(azo) dative bond. All Ag(azine) polymers have a 
1:1:1 stoichiometry for the Ag:bipyridyl:anion ratio and all have the expected 1-dimensional 
[Ag(bipyridyl)]n polymeric chain structure formed through Ag-N(pyridyl) bonds. Five of the seven 
structures, including all of the API structures, share a further bonding motif of individual chains being 
linked into pairs through Ag-Ag contacts and twin AgOXOAg (X = C or S) bridges. Similar bonding motifs 
are also known for related species with smaller anions. [1,2] Further intermolecular interactions 
between the double-chain structures are highly variable. Two structures, both with sulfonated azo dye 
anions, do not show the otherwise common bonding mode of Ag-Ag contacts and OXO (X= C or S) 
bridges. In these two cases, single chain [Ag(bipyridyl)]n structures with pendant anions are formed and 
inter-chain linkage is by long Ag-O, silver-to-anion contacts.   
Experimental 
Single Crystal Diffraction. Measurements were made at low temperature with Rigaku/Oxford Diffraction 
ŽƌŶƌĂĨEŽŶŝƵƐŝŶƐƚƌƵŵĞŶƚƐ ?DŽŶŽĐŚƌŽŵĂƚĞĚDŽ ?ʄA? ? ? ? ? ? ? ? )ƌĂĚŝĂƚŝŽŶǁĂƐƵƐĞĚĨŽƌĂůůĚĂƚĂ
ĐŽůůĞĐƚŝŽŶƐĞǆĐĞƉƚƚŚĂƚĨŽƌ ?Ő> ? ? ?ǇĞ ?ǁŚĞƌĞƵƌĂĚŝĂƚŝŽŶǁĂƐƵƐĞĚ ?ʄA? ? ? ? ?18 Å). Data for the 
diclofenac containing compounds and for [AgL3][DyeB].NCMe  and [AgL3][DyeC].solvate were measured 
by the NCS at the University of Southampton.[28] All structures were refined to convergence against F2 
and against all independent reflections using programs from the SHELX family. [29] Figures were drawn 
using MERCURY. [30] [AgL1][sal]  and [AgL2][Dye A] were modelled as twins. Selected crystallographic 
and refinement parameters are given in Tables 1 and 4 and full data has been deposited in cif format 
with the CCDC as CCDC 1517174 to 1517183. 
Synthesis. 
General Preparation of Ag salts. Example. Sodium salicylate (2 g, 12.8 mmol) was dissolved in water (10 
ml). Silver nitrate (3.6 g, 21 mmol (excess)) was dissolved in water (20 ml). The silver nitrate solution was 
then added to the salicylate solution and a white precipitate formed immediately. The precipitate was 
separated by filtration, washed with water and dried. Mass of product = 2.93 g (11.95 mmol). Yield = 
93.35 %.  All other Ag salts were formed in similar fashion and were generally used without further 
characterization. The exceptions being the Ag salt forms of Dye B and Dye C which were characterized 
ĐƌǇƐƚĂůůŽŐƌĂƉŚŝĐĂůůǇ ?ƐĞĞĂďŽǀĞ ) ?dŚŝƐƐŚŽǁĞĚƚŚĂƚ “ŐǇĞ ?ŝŶĨĂĐƚĐŽŶƚĂŝŶĞĚ ? ?ƚŽ ? ?A?ŽĨƌĞƐŝĚƵĂůEĂ ? 
General Preparation of Ag azine complexes. The azine ligands L1 to L3 were synthesised as described in 
reference 2. They gave IR spectra identical to the ligands previously reported. Sample preparation was 
also based on the methodology of reference 2. Thus in general dichloromethane solutions of the azine 
ligands were pipetted into nmr tubes. After leaving time to settle, acetonitrile solutions of the Ag salts 
were slowly pipetted into the tubes such that two layers were formed. Leaving the sealed tubes to sit 
resulted in slow mixing of the two solutions and their reagents with crystals forming within 1 to 7 days. 
Larger scale reactions for the salicylate and dye compounds, performed with mixing of reagents rather 
than layering, gave the same products (by comparison of IR spectra) as powders. Yields were 50 to 85 %. 
All possible combinations of L1, L2 and L3 with Ag salts of sal, diclofenac, Dye B and Dye C were 
attempted, but only the structures reported herein gave identifiable crystalline products that were not 
starting materials.  
 [AgL1][sal]. L1 (0.02 g, 0.1 mmol) was dissolved in dichloromethane (0.5 ml) and filtered. The solution 
was then pipetted into an NMR tube, a layer of blank acetonitrile (1 ml) was then pipetted into the NMR 
tube. Silver salicylate (0.05 g, 0.2 mmol) was dissolved in acetonitrile (1 ml), the silver salicylate solution 
was then pipetted into the same NMR tube giving two distinct layers. After one week crystalline material 
was obtained. IR (cm-1) KBr: 750, 820, 1142, 1248, 1309, 1354, 1390, 1419, 1456, 1487, 1554, 1599, 
3413. Raman, ʄA?633 nm (cm-1) : 1003, 1212, 1241, 1327, 1536, 1585, 1615.  
 [AgL2][sal]. L2 (0.02 g, 0.1 mmol) was dissolved in dichloromethane (0.5 ml) and filtered. The solution 
was then pipetted into an NMR tube, a layer of blank acetonitrile (1 ml) was then pipetted into the NMR 
tube. Silver salicylate (0.05 g, 0.2 mmol) was dissolved in acetonitrile (1 ml), the silver salicylate solution 
was then pipetted into the same NMR tube giving two layers. After five days yellow crystalline material 
was present. IR (cm-1): 639, 689, 765, 796, 948, 1001, 1124, 1196, 1292, 1383, 1423, 1446, 1579, 1636, 
2925. 
 [AgL2][diclofenac]. L2 (0.02 g, 0.1 mmol) was dissolved in dichloromethane (0.5 ml) and filtered. The 
solution was then pipetted into an NMR tube, a layer of blank acetonitrile (1 ml) was then pipetted into 
the NMR tube. Silver diclofenac (0.02 g, 0.05 mmol) was dissolved in acetonitrile (1 ml), the silver 
diclofenac solution was then pipetted into the same NMR tube forming two distinct layers. After 4 days 
crystalline material was present. IR (cm-1): 689, 764, 798, 943, 1038, 1105, 1167, 1195, 1256, 1312, 1352, 
1420, 1454, 1560, 1577, 2922, 2954. 
 [AgL3][diclofenac]. L3 (0.027 g, 0.1 mmol) was dissolved in dichloromethane (0.5 ml) and filtered. The 
solution was then pipetted into an NMR tube, a layer of blank acetonitrile (1 ml) was then pipetted into 
the NMR tube. Silver diclofenac (0.02 g, 0.05 mmol) was dissolved in acetonitrile (1 ml), the silver 
diclofenac solution was then pipetted into the same NMR tube forming two layers. After 5 days 
crystalline material was present.  
 [AgL2][DyeA]. L2 (0.033 g, 0.16 mmol) was dissolved in 1 ml of dichloromethane and filtered. The 
solution was pipetted into a nmr tube. AgDyeA (0.055 g, 0.16 mmol) was dissolved in 1 ml of acetonitrile 
and filtered. This solution was carefully layered onto the L3 solution and the tube was sealed. After 24 
hours, crystalline material appeared.  IR (cm-1): 702, 822, 866, 949, 971, 1023, 1083, 1120, 1188, 1225, 
1247, 1307, 1337, 1419, 1486, 1591, 1628, 2942. 
 [AgL3][DyeB]. L3 (0.019 g, 0.08 mmol) was dissolved in dichloromethane and filtered. A second filtered 
solution was prepared using AgDyeB (0.013 g, 0.04 mmol) and acetonitrile. Layering the two solutions in 
a nmr tube resulted in crystal growth at the interface after approximately 4 days. IR (cm-1) KBr: 581, 613, 
719, 833, 1029, 1131, 1222, 1282, 1422, 1605, 3452. 
 [AgL3][DyeC]. L3 (0.19 g, 0.8 mmol) was dissolved in dichloromethane and filtered. A second filtered 
solution was prepared using AgDyeC (0.12 g, 0.31 mmol) and acetonitrile. The solutions were layered 
together, split between several narrow tubes. This resulted in crystal growth at the interface after 
approximately 5 days. IR (cm-1) KBr: 573, 622, 708, 850, 1024, 1118, 1195, 1424, 1605, 3426. 
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